BackMoonLake Immunotherapeutics Overview

MoonLake Immunotherapeutics Total Assets

Latest total assets for MLTX: $400M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$400.37M
21.69% YoYΔ $-110.89M vs prior year quarter

Peer average

Loading

MoonLake Immunotherapeutics Total Assets History

Loading

MoonLake Immunotherapeutics vs. peers: Total Assets Comparison

Loading

MoonLake Immunotherapeutics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

MoonLake Immunotherapeutics (MLTX) FAQ

As of the most recent data (March 2026), MLTX shows a total assets of $400M. That compares with $510M in the prior-year period — down 21.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MLTX's total assets is now $400M (was $510M) — a 21.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether MoonLake Immunotherapeutics is outperforming or lagging.

Tracking MLTX's total assets over time shows whether MoonLake Immunotherapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $400M That compares with $510M in the prior-year period — down 21.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has MoonLake Immunotherapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $400M) with ownership activity and broader fundamentals.